Rapid advances have revolutionized the treatment of multiple myeloma, providing better disease control and prolonging ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

Blood cancer charity DKMS reached out to tell him that he had been identified as a match for a total stranger – a seriously ...

Insulin-producing human pancreas cells can be manufactured with 3D printers, researchers reported at the International Transplant Congress underway in London.

In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

Orca-T shows significant promise in reducing chronic graft-vs-host disease and improving survival rates in allogeneic ...

Stem cell therapies offer emerging hope for systemic sclerosis, with autologous and mesenchymal options under investigation ...

After a one-year follow-up, 10 of 12 patients given the islet cell therapy zimislecel no longer required insulin. Vertex ...

Two glioblastoma patients treated with Temferon have lived 3 years post-surgery; one had no progression, the other stabilized ...

The hepatitis E virus (HEV) causes severe liver inflammation. A research team from Ruhr University Bochum, Germany, and ...

Regeneron Pharmaceuticals said on Wednesday the U.S. Food and Drug Administration has approved its drug for a type of blood ...